Benvenisty, Nissim

The tumorigenicity of human embryonic and induced pluripotent stem cells

Ben-David, U., & Benvenisty, N. (2011) · Nature Reviews Cancer

Pluripotent Stem Cells ResearchCancer Cells and Metastasis

Cited by 889

Identification and classification of chromosomal aberrations in human induced pluripotent stem cells

Mayshar, Y., Ben-David, U., Lavon, N., Biancotti, J.-C., Yakir, B., Clark, A. T., Plath, K., Lowry, W. E., & Benvenisty, N. (2010) · Cell stem cell

Pluripotent Stem Cells ResearchGenomic variations and chromosomal abnormalities

Cited by 756

Pluripotent stem cells in disease modelling and drug discovery

Avior, Y., Sagi, I., & Benvenisty, N. (2016) · Nature Reviews Molecular Cell Biology

Pluripotent Stem Cells ResearchCRISPR and Genetic Engineering

Cited by 592

Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations

Merkle, F. T., Ghosh, S., Kamitaki, N., Mitchell, J., Avior, Y., Mello, C., Kashin, S., Mekhoubad, S., Ilic, D., Charlton, M., et al. (2017) · Nature

Pluripotent Stem Cells ResearchCancer Genomics and Diagnostics

Cited by 506

Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells

Drukker, M., Katchman, H., Katz, G., Even-Tov Friedman, S., Shezen, E., Hornstein, E., Mandelboim, O., Reisner, Y., & Benvenisty, N. (2006) · Stem Cells

Pluripotent Stem Cells ResearchXenotransplantation and immune response

Cited by 402

Assessing the Safety of Stem Cell Therapeutics

Goldring, C. E. P., Duffy, P. A., Benvenisty, N., Andrews, P. W., Ben-David, U., Eakins, R., French, N., Hanley, N. A., Kelly, L., Kitteringham, N. R., et al. (2011) · Cell Stem Cell

Biomedical Ethics and RegulationPluripotent Stem Cells Research

Cited by 245

Reversion of FMR1 methylation and silencing by editing the triplet repeats in Fragile X iPSC-derived neurons

Park, C.-Y., Halevy, T., Lee, D. R., Sung, J. J., Lee, J. S., Yanuka, O., Benvenisty, N., & Kim, D.-W. (2015) · Cell Reports

Genetics and Neurodevelopmental DisordersCRISPR and Genetic Engineering

Cited by 178

Defining essential genes for human pluripotent stem cells by CRISPR–Cas9 screening in haploid cells

Yilmaz, A., Peretz, M., Aharony, A., Sagi, I., & Benvenisty, N. (2018) · Nature Cell Biology

Pluripotent Stem Cells ResearchCRISPR and Genetic Engineering

Cited by 139

Study of hepatocyte differentiation using embryonic stem cells

Lavon, N., & Benvenisty, N. (2005) · Journal of Cellular Biochemistry

Pluripotent Stem Cells ResearchMesenchymal stem cell research

Cited by 134

ISSCR standards for the use of human stem cells in basic research

Ludwig, T. E., Andrews, P. W., Barbaric, I., Benvenisty, N., Bhattacharyya, A., Crook, J. M., Daheron, L. M., Draper, J. S., Healy, L. E., Huch, M., et al. (2023) · Stem Cell Reports

Pluripotent Stem Cells ResearchBiomedical Ethics and Regulation

Cited by 126

Two Yeast Homologs of ECA39, a Target for c-Myc Regulation, Code for Cytosolic and Mitochondrial Branched-chain Amino Acid Aminotransferases

Eden, A., Simchen, G., & Benvenisty, N. (1996) · Journal of Biological Chemistry

Fungal and yeast genetics researchAmino Acid Enzymes and Metabolism

Cited by 116

Analysis of chromosomal aberrations and recombination by allelic bias in RNA-Seq

Weissbein, U., Schachter, M., Egli, D., & Benvenisty, N. (2016) · Nature Communications

Genomic variations and chromosomal abnormalitiesGenomics and Phylogenetic Studies

Cited by 64